… metastatic non–small cell lung cancer (NSCLC), serious adverse … carboplatin and either paclitaxel or paclitaxel protein-bound … KEYTRUDA and chemotherapy (paclitaxel, paclitaxel protein-bound, or … carboplatin and either paclitaxel or paclitaxel protein-bound, …

… -pmph; Merck) plus paclitaxel, with or without bevacizumab … melanoma; non-small cell lung cancer; head and neck … berahyaluronidase alfa-pmph), Plus Paclitaxel ± Bevacizumab, Approved for … berahyaluronidase-alfa-pmph-plus-paclitaxel-%c2%b1-bevacizumab-approved- …

… phages specifically binding to lung cancer tumors. Principles of … Hydrophobic chemotherapeutics (eg, paclitaxel) often suffer from poor … applied to target lung cancer cells, especially brain … in lung cancer patients or using transplanted lung cancer animal …

… core symptoms among lung cancer survivors varied significantly … associated with paclitaxel-based chemotherapy.58 Paclitaxel-based … chemotherapy that contained paclitaxel-based medicines. Pain … core symptom changes in lung cancer survivors: a longitudinal …

… elderly patients with advanced lung cancer who are unsuitable … -line chemotherapy with nab-paclitaxel (400 mg) was … NSCLC, non-small cell lung cancer; PFS, prolonged progression-free … for a lung cancer: a narrative review. Transl Lung Cancer Res. 2021 …

… non-small cell lung cancer patients treated with … cell lung cancer from an Italian knowledge-based database. Lung Cancer. … of paclitaxel on gefitinib-resistant non-small cell lung cancer cells … in non-small cell lung cancer: reproducibility and implications …

… agents, such as nab-paclitaxel, can attenuate the immunosuppressive … and non–small cell lung cancer.24 However, its combination … non-squamous non-small-cell lung cancer (CameL): a randomised, … comparative effectiveness of nab-paclitaxel plus gemcitabine versus …

… CRISPR) technology can make lung cancer cells responsive to chemotherapy again … lung cancer (NSCLC) that represents 20% to 30% of all lung cancer … 47;Cas9 to engineer lung cancer cells carrying the R34G … such as carboplatin and paclitaxel. In animal models, …

… lower lobe received neoadjuvant carboplatin, paclitaxel, and nivolumab therapy. Although … response to neoadjuvant therapy in lung cancer. The term describes an apparent … of neoadjuvant chemoimmunotherapy with carboplatin, paclitaxel, and nivolumab. A repeat …

… landscape for resistant lung tumors. Researchers at Christiana … NRF2 gene restores lung cancer cells’ sensitivity to … lung cancer that accounts for 20-30% of lung cancer cases. Scientists engineered lung cancer … like carboplatin and paclitaxel, slowing tumor …